Literature DB >> 16269129

Endothelial stress induces the release of vitamin D-binding protein, a novel growth factor.

Marc-André Raymond1, Anik Désormeaux, Andrée Labelle, Mathilde Soulez, Gilles Soulez, Yves Langelier, Alexey V Pshezhetsky, Marie-Josée Hébert.   

Abstract

Endothelial cells (EC) under stress release paracrine mediators that facilitate accumulation of vascular smooth muscle cells (VSCM) at sites of vascular injury. We found that medium conditioned by serum-starved EC increase proliferation and migration of VSCM in vitro. Fractionation of the conditioned medium followed by mass spectral analysis identified one bioactive component as vitamin D-binding protein (DBP). DBP induced both proliferation and migration of VSMC in vitro in association with increased phosphorylation of ERK 1/2. PD 98059, a biochemical inhibitor of ERK 1/2, abrogated these proliferative and migratory responses in VSMC. DBP is an important carrier for the vitamin-D sterols, 25-hydroxyvitamin-D, and 1alpha,25-dihydroxyvitamin-D. Both sterols inhibited the activity of DBP on VSMC, suggesting that vitamin D binding sites are important for initiating the activities of DBP on VSMC. Release of DBP at sites of endothelial injury represents a novel pathway favoring accumulation of VSMC at sites of vascular injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269129     DOI: 10.1016/j.bbrc.2005.10.105

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  24 in total

1.  Vitamin D and Atherosclerotic Cardiovascular Disease.

Authors:  Thomas Hiemstra; Kenneth Lim; Ravi Thadhani; JoAnn E Manson
Journal:  J Clin Endocrinol Metab       Date:  2019-04-04       Impact factor: 5.958

2.  Vitamin D binding protein in COVID-19.

Authors:  Marijn M Speeckaert; Reinhart Speeckaert; Joris R Delanghe
Journal:  Clin Med (Lond)       Date:  2020-09       Impact factor: 2.659

3.  Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease.

Authors:  Amit R Patange; Rudolph P Valentini; Wei Du; Michael D Pettersen
Journal:  Pediatr Cardiol       Date:  2011-09-13       Impact factor: 1.655

4.  Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans.

Authors:  Ibhar Al Mheid; Riyaz Patel; Jonathan Murrow; Alanna Morris; Ayaz Rahman; Lucy Fike; Nino Kavtaradze; Irina Uphoff; Craig Hooper; Vin Tangpricha; R Wayne Alexander; Kenneth Brigham; Arshed A Quyyumi
Journal:  J Am Coll Cardiol       Date:  2011-07-05       Impact factor: 24.094

Review 5.  Vitamin D in Cardiovascular Disease.

Authors:  Alkippi Nitsa; Marina Toutouza; Nikolaos Machairas; Anargyros Mariolis; Anastassios Philippou; Michael Koutsilieris
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

Review 6.  Vitamin D deficiency and toxicity in chronic kidney disease: in search of the therapeutic window.

Authors:  Uwe Querfeld; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-06-22       Impact factor: 3.714

Review 7.  Vitamin D and regulation of vascular cell function.

Authors:  Nasim Jamali; Christine M Sorenson; Nader Sheibani
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

8.  Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities.

Authors:  David F Moore; Oleg V Krokhin; Ronald C Beavis; Markus Ries; Chevalia Robinson; Ehud Goldin; Roscoe O Brady; John A Wilkins; Raphael Schiffmann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-14       Impact factor: 11.205

9.  Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology.

Authors:  M Moon; H Song; H J Hong; D W Nam; M-Y Cha; M S Oh; J Yu; H Ryu; I Mook-Jung
Journal:  Cell Death Differ       Date:  2012-12-21       Impact factor: 15.828

Review 10.  The effect of vitamin D status on risk factors for cardiovascular disease.

Authors:  Sujana S Gunta; Ravi I Thadhani; Robert H Mak
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.